Effects of different exercise intensities on visfatin level and glucose metabolism in type 2 diabetic rats

doi:10.3969/j.issn.2095-4344.2766

Abstract

Abstract:

BACKGROUND: Visfatin has an insulin-like hypoglycemic effect with positive significance in the treatment of type 2 diabetes. Different exercise intensities have different effects on the level of visfatin.

OBJECTIVE: To observe the effects of 6-week aerobic exercise of different intensities on glucose metabolism and the level of visfatin in type 2 diabetic rats and to explore the relationship between them.

METHODS: The male Sprague-Dawley rats were fed with high-fat diet and injected with streptozotocin to establish a type 2 diabetes model. The 43 model rats were randomly divided into quiet control group (n=10), exercise group I (n=11), exercise group II (n=11) and exercise group III (n=11). The exercise intensities of the three exercise groups were 10, 15, and 20 m/min, respectively. Exercises of different intensities were performed 1 h/d, 5 days per week, for 6 continuous weeks. Blood samples were collected at the end of 6 weeks for determination of glucose metabolism-related indicators and serum and visceral levels of visfatin.

RESULTS AND CONCLUSION: The indexes related to glucose metabolism (fasting blood glucose, glycosylated serum protein, insulin, insulin resistance index, etc.) in the three exercise groups were improved. The serum level of visfatin in the exercise groups I and II were significantly decreased (P < 0.01), while the serum level of visfatin in the exercise group III was decreased to some extent, but not significantly (P > 0.05). There was a significant decrease in visfatin level in the three exercise groups (P < 0.05), especially in the exercise group II (P < 0.01). The results indicate that low-intensity aerobic exercise can effectively improve insulin resistance and reduce blood glucose concentration in type 2 diabetic rats, and it is related to the loss of visceral fat and the reduction of visfatin secretion, where visfatin may play a positive role.

Key words: aerobic exercise, rats, type 2 diabetes, visfatin, visceral fat, insulin resistance, high-fat diet, insulin, glucose metabolism, streptozotocin

CLC Number:

Li Ying, Lin Wentao, Weng Xiquan.

Effects of different exercise intensities on visfatin level and glucose metabolism in type 2 diabetic rats [J]. Chinese Journal of Tissue Engineering Research, 2020, 24(26): 4196-4200.

Figures/Tables 4

References

[1] WANG T, HE C. Pro-inflammatory cytokines: the link between obesity and osteoarthritis. Cytokine Growth Factor Rev. 2018; 44:38-50.

[2] ROMACHO T, ELSEN M, RÖHRBORN D, et al. Adipose tissue and its role in organ crosstalk. Acta Physiol. 2014;210(4):733-753.

[3] SOUNDARRAJAN M, DENG J, KWASNY M, et al. Activated brown adipose tissue and its relationship to adiposity and metabolic markers: an exploratory study. Adipocyte. 2020;9(1): 87-95.

[4] FUKUHARA A, MATSUDA M, NISHIZAWA M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307(5708):426-430.

[5] GOK DE, YAZICI M, UCKAYA G, et al. The role of visfatin in the pathogenesis of gestational diabetes mellitus. J Endocrinol Invest. 2011;34(1):3-7.

[6] 余臣祖,张朝宁.实验性T2DM动物模型研究进展[J].医学综述,2006, 12(1):41-42.

[7] BEDFORD TG, TIPTON CM, WILSON NC, et al. Maximum oxygen consumption of rats and its changes with various experimental procedures. J Appl Physiol Respir Environ Exerc Physiol. 1979;47(6):1278-1283.

[8] 俞静.内脏脂肪棕色化功能改变影响肥胖的分子机制研究[D].南京:南京医科大学,2013.

[9] 唐丽丽,汤晓涵,李霞等.高糖和高脂饮食对小鼠肥胖和内脏脂肪的影响[J].中国医学科学院学报,2014,36(6):614-619.

[10] 孔小岑.糖皮质激素通过miR-27b调控白色脂肪棕色化功能的分子机理研究[D].南京:南京医科大学,2013.

[11] HAFFNER SM, GONZALEZ C, MIETTINEN H, et al. A prospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes care. 1996;19(10):1138-1141.

[12] BRUCE CR, HAWLEY JA. Improvements in insulin resistance with aerobic exercise training: a lipocentric approach. Med Sci Sports Exerc. 2004;36(7):1196-1201.

[13] IVY JL. Muscle insulin resistance amended with exercise training: role of GLUT4 expression. Med Sci Sports Exerc. 2004;36(7): 1207-1211.

[14] DOHM GL, SINHA MK, CARO JF. Insulin receptor binding and protein kinase activity in muscles of trained rats. Am J Physiol. 1987;252(2 Pt 1):E170-E175.

[15] KURYSZKO J, SŁAWUTA P, SAPIKOWSKI G. Secretory function of adipose tissue. Pol J Vet Sci. 2016;19(2):441-446.

[16] SULAIEVA O, CHERESHNEVA Y, KARTASHKINA N, et al. Secretory function of white adipose tissue and adipokines: biological effects and clinical significance (review). Georgian Med News. 2018;(274):116-124.

[17] CHEN MP, CHUNG FM, CHANG DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2006;91(1):295-299.

[18] DOGRU T, SONMEZ A, TASCI I, et al. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract. 2007;76(1):24-29.

[19] RAHMOUNI K, CORREIA MLG, HAYNES WG, et al. Obesity-associated hypertension: new insights into mechanisms. Hypertension. 2005;45(1):9-14.

[20] OLSZANECKA-GLINIANOWICZ M, KOCEŁAK P, NYLEC M, et al. Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndrome. Arch Med Sci. 2012;8(2):214.

[21] KOWALSKA I, KARCZEWSKA-KUPCZEWSKA M, ADAMSKA A, et al. Serum visfatin is differentially regulated by insulin and free fatty acids in healthy men. J Clin Endocrinol Metab. 2013;98(2): E293-E297.

[22] AUGUET T, TERRA X, PORRAS JA, et al. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease. Clin Biochem. 2013;46(3):202-208.

[23] MATHSA TE, ISMAIL SV, SPEELMAN A, et al. Visceral and subcutaneous adipose tissue association with metabolic syndrome and its components in a South African population. Clin Nutr ESPEN. 2019;10(1016):76-78.

[24] NOURBAKHSH M, NOURBAKHSH M, GHOLINEJAD Z, et al. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome. Scand J Clin Lab Invest. 2015;75(2):183-188.

[25] KAMIŃSKA A, KOPCZYŃSKA E, BRONISZ A, et al. An evaluation of visfatin levels in obese subjects. Endokrynol Polska. 2010; 61(2):169-173.

[26] USLU S, KEBAPÇI N, KARA M, et al. Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus. Exp Ther Med. 2012;4(1):113-120.

[27] STROMSDORFER KL, YAMAGUCHI S, YOON MJ, et al. NAMPT-mediated NAD+ biosynthesis in adipocytes regulates adipose tissue function and multi-organ insulin sensitivity in mice. Cell Rep. 2016;16(7):1851-1860.

[28] TRON'KO ND, ZAK KP. Obesity and diabetes mellitus. Lik Sprava. 2013;(8):3-21.

[29] BANERJEE S, TALUKDAR I, BANERJEE A, et al. Type II diabetes mellitus and obesity: common links, existing therapeutics and future developments. J Biosci. 2019;44(6):150.

[30] ROMACHO T, AZCUTIA V, VAZQUEZ-BELLA M, et al. Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity. Diabetologia. 2009;52(11):2455-2463.